Tag: BDRX

Science

Why Do Investors Buy Stock In Biodexa Pharmaceuticals Plc ADR (BDRX)?

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) has a beta value of 1.58 and has seen 1.67 million shares traded in the recent trading session. The company,

Technologies

Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) At $1.27 Is Worth A Gamble

During the recent session, Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s traded shares were 43.71 million, with the beta value of the company hitting 1.68. At the

Technologies

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) Is Worth Considering At $1.62

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s traded shares stood at 87.97 million during the last session, with the company’s beta value hitting 1.43. At the close

Science

Biodexa Pharmaceuticals Plc ADR At $1.68: Buy, Sell Or Hold?

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s traded shares stood at 62.86 million during the latest session, with the company’s beta value hitting 1.43. At the last

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: BDRX

Why Do Investors Buy Stock In Biodexa Pharmaceuticals Plc ADR (BDRX)?

Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) At $1.27 Is Worth A Gamble

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) Is Worth Considering At $1.62

Biodexa Pharmaceuticals Plc ADR At $1.68: Buy, Sell Or Hold?

Quick Links

Categories